JPS6422A - Prophylactic and remedy for hypocalcemia and bone catabolism - Google Patents
Prophylactic and remedy for hypocalcemia and bone catabolismInfo
- Publication number
- JPS6422A JPS6422A JP62085436A JP8543687A JPS6422A JP S6422 A JPS6422 A JP S6422A JP 62085436 A JP62085436 A JP 62085436A JP 8543687 A JP8543687 A JP 8543687A JP S6422 A JPS6422 A JP S6422A
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- preparation
- remedy
- prophylactic
- hypocalcemia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000069 prophylactic effect Effects 0.000 title abstract 2
- 208000013038 Hypocalcemia Diseases 0.000 title 1
- 210000000988 bone and bone Anatomy 0.000 title 1
- 230000015556 catabolic process Effects 0.000 title 1
- 230000000705 hypocalcaemia Effects 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 5
- 229910052791 calcium Inorganic materials 0.000 abstract 5
- 239000011575 calcium Substances 0.000 abstract 5
- 239000004480 active ingredient Substances 0.000 abstract 2
- NDVRKEKNSBMTAX-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;phosphoric acid Chemical compound OP(O)(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O NDVRKEKNSBMTAX-BTVCFUMJSA-N 0.000 abstract 1
- 229910019142 PO4 Inorganic materials 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 230000037118 bone strength Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000010452 phosphate Substances 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Landscapes
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
PURPOSE: To obtain a prophylactic preparation or a remedy for diseases caused by insufficiency of calcium in living body tissues, by using calcium hexosephosphate as an active ingredient, thus enabling the drug to be administered for a long period of time without side-actions.
CONSTITUTION: Calcium hexose-phosphate, preferably calcium glucose-phosphate is used, as an active ingredient, to give the subject preparation. The preparation has good absorption properties, increases the calcium concentration in blood and strengthens bone strength. The dose of the preparation is 1W50g, preferably 10W30g/day/adult.
COPYRIGHT: (C)1989,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62085436A JPS6422A (en) | 1987-02-12 | 1987-04-07 | Prophylactic and remedy for hypocalcemia and bone catabolism |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62-30513 | 1987-02-12 | ||
| JP3051387 | 1987-02-12 | ||
| JP62085436A JPS6422A (en) | 1987-02-12 | 1987-04-07 | Prophylactic and remedy for hypocalcemia and bone catabolism |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPH0122A JPH0122A (en) | 1989-01-05 |
| JPS6422A true JPS6422A (en) | 1989-01-05 |
| JPH0541606B2 JPH0541606B2 (en) | 1993-06-24 |
Family
ID=12305891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62085436A Granted JPS6422A (en) | 1987-02-12 | 1987-04-07 | Prophylactic and remedy for hypocalcemia and bone catabolism |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6422A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1477171A1 (en) | 2003-05-16 | 2004-11-17 | Kao Corporation | Intestinal mineral absorption capacity improver |
| JP2005002090A (en) * | 2003-05-16 | 2005-01-06 | Kao Corp | Vitamin D-like active substitute |
-
1987
- 1987-04-07 JP JP62085436A patent/JPS6422A/en active Granted
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1477171A1 (en) | 2003-05-16 | 2004-11-17 | Kao Corporation | Intestinal mineral absorption capacity improver |
| JP2005002090A (en) * | 2003-05-16 | 2005-01-06 | Kao Corp | Vitamin D-like active substitute |
| JP2005002091A (en) * | 2003-05-16 | 2005-01-06 | Kao Corp | Intestinal mineral absorption capacity improver |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0541606B2 (en) | 1993-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2139892B (en) | Solid pharmaceutical preparation containing nifedipine | |
| ID24901A (en) | METHOD OF TREATMENT OF HIGH COAGAGULATION OR DEFICIENCY OF PROTEIN C OBTAINED | |
| CA2024419A1 (en) | Novel bivalent metal salts of n,n-di(carboxymethyl)-2-amino-3-cyano-4-carboxymethyl-5-carboxythiophene acid, process for their preparation and pharmaceutical compositions containing them | |
| DK339289D0 (en) | PHARMACEUTICAL PREPARATION | |
| Minot et al. | Use of guanidine hydrochloride in treatment of myasthenia gravis | |
| IE890580L (en) | Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants | |
| EP0388799A3 (en) | Use of human interferon-beta for stimulation of erythropoieses | |
| DE69401502D1 (en) | Pharmaceutical preparation for producing a stabilized powder which contains a combination of acetylsalicylic acid and metoclopramide as the active ingredient | |
| KR900007434A (en) | Therapeutics with cystatin as active ingredients | |
| KR100271087B1 (en) | Protein synthesis stimulator comprising tcf-2 for the treatment of hypoproteinemia | |
| RU92001958A (en) | METHOD OF OBTAINING FIBRINE PASTE | |
| TWI263502B (en) | Pharmaceutical preparation for treating ischemic disease of heart or limbs | |
| Goldstein et al. | Cutaneous complications of heart transplantation | |
| Blanchet et al. | Effects of methyl methacrylate monomer vapors on respiration and circulation in unanesthetized rats | |
| Laszlo et al. | Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate | |
| KR880002521A (en) | Pharmaceutical formulation | |
| ATE66375T1 (en) | USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES. | |
| Sonnenblick et al. | Digoxin treatment and control in the elderly | |
| Kanniainen et al. | Antihypertensive effects of urapidil and clonidine: a double-blind cross-over study | |
| RU2065276C1 (en) | Prophylaxis agent | |
| RU2000108316A (en) | METHOD FOR PREVENTION OF DETENTION OF POST-NEXT AND POST-PERMANT PATHOLOGY IN COWS | |
| Pinterova et al. | The effect of bopindolol on lipids and platelet aggregation | |
| JPS643123A (en) | Remedy for skin inflammation | |
| Hazelrigg et al. | Dietary fluoride supplements for Indiana's children: the role of the physician | |
| Kukletová et al. | Oxazepam to stomatologic patients who do not cooperate. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term | ||
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070624 Year of fee payment: 14 |